NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

HSE CEO powers to approve high-value contracts remains in place

By Mindo - 21st Sep 2021

Close up of unrecognizable man signing a contract on a meeting with his agent.

A delegation of all necessary authority to the HSE CEO to approve expenditure associated with the Covid-19 pandemic remains in place, an Executive spokesperson has said. “The delegation is subject to board oversight, has been discussed at board level, and remains in place until such time as it is revoked by the board of the HSE,” they outlined.

As previously reported by the Medical Independent, Mr Paul Reid can approve Covid-19 contracts worth over €10 million and accept ‘gifts’ to the HSE exceeding €100,000 without board approval. Contract approvals would be subject to the agreement of the Department of Public Expenditure and Reform and Department of Health.

According to the HSE, typical examples of the CEO approval of contracts over the course of the pandemic would include those for the supply of personal protective equipment (PPE) and separate contracts for the supply of face masks; and contracts for the provision of Covid-19 testing services and for a dual amplitude Covid-19 testing system.

“The value of contracts with individual suppliers is commercially-sensitive information. The CEO did not approve any gifts.” Asked if the delegation had been cited in any audits of expenditure, the HSE spokesperson said: “The amended delegation to the CEO was cited in the audit of PPE undertaken by KPMG (June 2021). However, it was referenced not in the context of ensuring value for money, but rather in the context of the sign-off of purchase orders.”

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read